National and Kapodistrian University of Athens
Η επίδραση της φόρτισης με γλυκόζη και της κατάλληλης υπογλυκαιμικής και αντιλιπιδαιμικής αγωγής στην ενδοθηλιακή λειτουργία και τους φλεγμονώδεις παράγοντες σε ασθενείς με αρχόμενο σακχαρώδη διαβήτη τύπου 2
Abstract
dc:descriptionStatin treatment has been suggested to improve survival in patients with atherosclerosis, partly by improving vascular endothelial function. The elevation of blood glucose levels results into an impairment of endothelial function that promotes atherogenesis, but the effect of statins on glucose-induced impairment of endothelial function and variations of inflammatory markers, is still unknown. We examined the effect of combined therapy with atorvastatin and metformin on glucose-induced endothelial dysfunction and glucose-induced variations of inflammatory molecules in patients with newly diagnosed diabetes mellitus type 2 (DM). Sixty-seven Caucasian subjects with newly diagnosed DM were randomized to receive dietary instructions (n=19, 13 males, 61 + 11.7 years old, BMI: 27.7±3.4 kg/m2) or dietary instructions and atorvastatin 10mg/d (n=15, 8 males, 61.1 + 8.6 years old, BMI: 30.6±6.4 kg/m2) or metformin 850mg/d (n=17, 12 males, age 53.8 + 11 years old, BMI: 28.7±4.5 kg/m2) or metformin 850mg/d and atorvastatin 10mg/d (n=16, 7 males, age 53.1+9.5 years old, BMI: 28.5± 2.1 kg/m2) for 12 weeks, in an open label study. All subjects underwent glucose loading (75gr oral glucose after 12 hours of fasting) at baseline and at the end of the treatment period. Blood samples were obtained at baseline and 3 hours post-loading, while endothelium dependent dilation (EDD, measured by gauge-strain plethysmography) was evaluated at baseline and at 1, 2 and 3 hours post-loading. In addition, serum tumor necrosis factor alpha (TNF-α) and E-selectin levels were determined at baseline and at 3h. The investigators were blinded to the treatment regiments, and all analyses were performed in a blinded way. At baseline, EDD was reduced 1 and 2 hours after glucose-loading in all the study groups (p<0.001). Glucose loading induced an elevation of blood glucose levels at 1 and 2 hours (p<0.001 vs baseline) and returned to baseline at 3 hours, in all groups at baseline and post-treatment. Metformin alone or in combination with atorvastatin significantly reduced resting glucose levels after 12 weeks (p<0.05 for both vs baseline), but only metformin plus atorvastatin partly prevented the glucose-induced elevation of serum glucose at 1h post-loading (p<0.001 vs baseline) and the glucoseinduced decrease of EDD (p<0.05 vs baseline). 167 Serum TNF-α remained unchanged in metformin group at baseline (from 1.36±0.18 to 1.47±0.21 pg/ml p=NS) and after treatment (from 1.44±0.71 to 1.31±0.17 pg/ml, p=NS), while it was reduced in metformin plus atorvastatin group (from 2.3±0.3 to 2.0±0.4 pg/ml, p=NS at baseline and from 1.80±0.2 to 1.65±0.2 pg/ml, p=0.03 after treatment). Serum sE-sel remained unchanged after loading at baseline in metformin group (from 51.0±4.9ng/ml to 49.7±5.3ng/ml, p=NS) and after treatment (from 45.51±3.4ng/ml to 43.3±3.9ng/ml, p=NS), and were reduced in metformin plus atorvastatin group (from 44.2±5.6ng/ml to 41.5±6.2ng/ml, p=NS at baseline, and from 40.8±5.4 to 36.8±5.1ng/ml, p<0.05 after treatment). Glucose-loading blunted endothelial function in patients with newly-diagnosed DM type 2. However, combined treatment with atorvastatin and metformin for 12 weeks, partly prevented the glucose-induced impairment of endothelium dependent dilatation in these subjects and it was statistically significantly better than monotherapy with metformin. In addition, the combination therapy of metformin and atorvastatin partly prevented the glucose-loading induced elevation of glucose levels (at 1 hour), suggesting a better response to glucose intake than monotherapy with metformin and improvement of insulin resistance. Moreover, combined treatment with atorvastatin and metformin reduced the post-glucose loading levels of TNF-α and E-selectin compared to metformin monotherapy, suggesting a better anti-inflammatory effect of the combination therapy.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koniari, Katerina
- Κόνιαρη, Αικατερίνη
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29794